Androgen Receptor Status in Triple Negative Breast Cancer: Does It Correlate with Clinicopathological Characteristics?

AL Dubrava, PSP Kyaw, J Newman… - … Cancer: Targets and …, 2023 - Taylor & Francis
Purpose Triple negative breast cancer (TNBC) is a breast carcinoma subtype that neither
expresses estrogen (ER) and progesterone receptors (PR) nor the human epidermal growth …

[PDF][PDF] Serum levels of selenium and zinc in patients with breast cancer: A case-control study

SM Hashemi, M Sadeghi, AV Tabas… - International Journal of …, 2017 - brieflands.com
Background: Zinc (Zn) and Selenium (Se) are trace minerals that have high anti-cancer and
chemopreventive properties. Objectives: This study aimed at evaluating the serum levels of …

[PDF][PDF] Prevalence of androgen receptors expression in triple negative breast cancer patients and its correlation with clinicopathological criteria: our institutes …

K Farag, OM Elfarargy, S El Shorbagy… - Menopause. J Clin …, 2017 - secioj.journals.ekb.eg
Background: Triple negative breast cancer (TNBC) is a term that has been applied to breast
cancers which lack expression of three receptors: estrogen receptor (ER), progesterone …

[PDF][PDF] Triple-negative breast cancer: from classical clinicopathological features to androgen receptor profile

I PRUTIANU, SE GIUŞCĂ, B GAFTON, MB CHIFU… - lung cancer - rjme.ro
Triple-negative breast cancer (BC) represents an extensively analyzed entity to establish the
overall framework of clinicopathological characteristics, with an impact on defining …

雄激素受体对三阴性乳腺癌患者生存状况影响的Meta 分析

张成帅, 潘翠柳, 高亚男, 韩冰, 张志茹… - 吉林大学学报(医学版 …, 2017 - xuebao.jlu.edu.cn
Objective: To evaluate the influence of androgen receptor (AR) in the living conditions in the
triple-negative breast cancer patients, and to explore whether there is a difference in the …

Androgen receptor expression in a Sri Lankan patient cohort with early breast carcinoma

HD Wijesinghe, GK Wijesinghe, Z Mansoor… - BMC Women's …, 2020 - Springer
Background Androgen receptor (AR) expression is emerging as a prognostic biomarker in
breast carcinoma (BCa). The study aimed to determine the prevalence of AR expression by …

The association between androgen receptor expression and some pathological characteristics in patients with breast cancer

M Azizi, S Madani, B Izadi, S Khazaei… - Clinical Cancer …, 2021 - ccij-online.org
Context: Breast cancer is the most current malignancy in women all around the world.
Considering the presence of the androgen receptor as a possible prognostic marker …

Характеристики взаимодействия miR-1322 c mRNA генов, участвующих в развитии рака молочной железы

D Aisina, E Imyanitov, A Ivashchenko - Вестник КазНУ. Серия …, 2017 - bb.kaznu.kz
Аннотация Работа посвящена нахождению сайтов связывания miR-1322 в mRNA
кандидатных генов AFF3, AR, ARID3B, E2F4, NCOA3, NCOR2, SMARCA2, участвующих …

Features of miR-1322 binding sites in the coding area of mRNA orthologic genes

D Aisina, O Yurikova, A Ivashchenko - Moscow Conference on …, 2017 - elibrary.ru
MiR-1322 can regulate the expression of genes that are involved in the development of
cancer, cardiovascular and neurodegenerative diseases [1]. It is important to identify the …

[引用][C] Serum zinc and selenium levels in breast cancer women: A report from Southeastern Iran

SM Hashemi, M Sadeghi, AV Tabas, S Bouya… - Health Sciences, 2016